Published in Am J Manag Care on August 01, 2009
Travel distance and home dialysis rates in the United States. Perit Dial Int (2014) 2.04
Adipose tissue-derived mesenchymal stem cells in long-term dialysis patients display downregulation of PCAF expression and poor angiogenesis activation. PLoS One (2014) 1.52
Neighborhood socioeconomic status and barriers to peritoneal dialysis: a mixed methods study. Clin J Am Soc Nephrol (2013) 1.02
Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan. Perit Dial Int (2013) 0.93
In Peritoneal Dialysis, Is There Sufficient Evidence to Make "PD First" Therapy? Int J Nephrol (2011) 0.87
Peritoneal dialysis in Cape Town, South Africa. Perit Dial Int (2012) 0.83
Monthly cost of three exchanges a day peritoneal dialysis is same as of thrice a week hemodialysis in self-paying Indian patients. Indian J Nephrol (2012) 0.82
Radiological insertion of Tenckhoff catheters for peritoneal dialysis: a 1-year single-centre experience. Clin Kidney J (2013) 0.82
Diagnosis and management of chronic kidney disease in the elderly: a field of ongoing debate. Aging Dis (2012) 0.81
Laparoscopic versus open peritoneal dialysis catheter insertion, the LOCI-trial: a study protocol. BMC Surg (2011) 0.80
Evaluation of the National Kidney Foundation of Hawai'i's Kidney Early Detection Screening program. Hawaii J Med Public Health (2012) 0.79
Behavioral stage of change and dialysis decision-making. Clin J Am Soc Nephrol (2015) 0.79
A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil. Perit Dial Int (2012) 0.79
Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis. Perit Dial Int (2013) 0.77
A Novel Mouse Model of Peritoneal Dialysis: Combination of Uraemia and Long-Term Exposure to PD Fluid. Biomed Res Int (2015) 0.77
Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US. Clinicoecon Outcomes Res (2013) 0.76
Can dialysis patients be accurately identified using healthcare claims data? Perit Dial Int (2014) 0.75
Association of Adiponectin with High-Sensitivity C-Reactive Protein and Clinical Outcomes in Peritoneal Dialysis Patients: A 3.5-Year Follow-Up Study. PLoS One (2015) 0.75
Effects of physician payment reform on provision of home dialysis. Am J Manag Care (2016) 0.75
Evaluating the benefits of home-based peritoneal dialysis. Int J Nephrol Renovasc Dis (2014) 0.75
The mode of pretransplant dialysis does not affect postrenal transplant outcomes in african americans. J Transplant (2012) 0.75
Cluster analysis and its application to healthcare claims data: a study of end-stage renal disease patients who initiated hemodialysis. BMC Nephrol (2016) 0.75
Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden. BMJ Open (2016) 0.75
Economic burden of chronic kidney disease in Korea using national sample cohort. J Nephrol (2017) 0.75
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest (2002) 6.13
Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2006) 5.86
Population-wide benefits of routine vaccination of children against influenza. Vaccine (2005) 2.68
Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50 years. Vaccine (2012) 2.43
Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis (2009) 2.41
Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med (2003) 2.39
Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study. Diabetes Care (2003) 2.29
The health-related quality of life and economic burden of constipation. Pharmacoeconomics (2005) 2.14
Therapy switching in patients receiving long-acting opioids. Ann Pharmacother (2004) 2.14
Outcomes and costs of risperidone versus olanzapine in patients with chronic schizophrenia or schizoaffective disorders: a Markov model. Value Health (2004) 2.05
Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain (2004) 1.92
Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer (2006) 1.61
Is sepsis accurately coded on hospital bills? Value Health (2002) 1.60
Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion (2007) 1.60
Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia. Ann Pharmacother (2011) 1.58
Clinical and economic burden of pneumococcal disease in older US adults. Vaccine (2010) 1.55
Pain, medication use, and health-related quality of life in older persons with postherpetic neuralgia: results from a population-based survey. J Pain (2005) 1.53
The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health (2004) 1.52
Defining clinically meaningful outcomes in the evaluation of new treatments for oral mucositis: oral mucositis patient provider advisory board. Cancer Invest (2002) 1.49
The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer. Oncology (2004) 1.47
Clinical and economic consequences of failure of initial antibiotic therapy for hospitalized patients with complicated skin and skin-structure infections. Infect Control Hosp Epidemiol (2008) 1.41
Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Vaccine (2009) 1.40
Opioid use and health care charges at the end of life in patients with metastatic cancer. Manag Care Interface (2004) 1.38
Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant (2008) 1.37
Healthcare costs in women with metastatic breast cancer receiving chemotherapy as their principal treatment modality. BMC Cancer (2011) 1.30
Retrospective study of the effect of skeletal complications on total medical care costs in patients with bone metastases of breast cancer seen in typical clinical practice. J Support Oncol (2006) 1.28
Economic costs of nonmedical use of prescription opioids. Clin J Pain (2011) 1.22
Are shorter courses of filgrastim prophylaxis associated with increased risk of hospitalization? Ann Pharmacother (2006) 1.15
Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health Syst Pharm (2006) 1.12
Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer (2013) 1.10
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: a retrospective cohort study. Clin Ther (2009) 1.10
Risk-factor clustering and cardiovascular disease risk in hypertensive patients. Am J Hypertens (2007) 1.10
Economic consequences of failure of initial antibiotic therapy in hospitalized adults with complicated intra-abdominal infections. Surg Infect (Larchmt) (2008) 1.09
Medical visits among adults with symptoms commonly associated with an overactive bladder. BJU Int (2006) 1.07
Resource utilization and costs before and after total joint arthroplasty. BMC Health Serv Res (2012) 1.06
The incidence and cost of hospitalization for 5-FU toxicity among Medicare beneficiaries with metastatic colorectal cancer. Value Health (2002) 1.04
Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies. Support Care Cancer (2006) 1.02
Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J Clin Microbiol (2010) 1.02
Use of oral antithrombotic agents among health maintenance organization members with atherosclerotic cardiovascular disease. Arch Intern Med (2002) 1.01
Clinical and economic consequences of bleeding following major orthopedic surgery. Thromb Res (2006) 1.01
Effectiveness of bisphosphonate therapy in a community setting. Bone (2008) 1.01
Risk and healthcare costs of chemotherapy-induced neutropenic complications in women with metastatic breast cancer. Chemotherapy (2012) 1.00
Mortality risk by functional status and health-related quality of life in patients with rheumatoid arthritis. J Rheumatol (2011) 1.00
Dose intensification with infliximab in patients with rheumatoid arthritis. Ann Pharmacother (2005) 1.00
Comparative effectiveness of filgrastim, pegfilgrastim, and sargramostim as prophylaxis against hospitalization for neutropenic complications in patients with cancer receiving chemotherapy. Am J Clin Oncol (2012) 0.99
Gaining efficiencies: resources and demand for dialysis around the globe. Value Health (2008) 0.99
Dialysis facility and patient characteristics associated with utilization of home dialysis. Clin J Am Soc Nephrol (2010) 0.98
Healthcare costs in patients with metastatic lung cancer receiving chemotherapy. BMC Health Serv Res (2011) 0.98
Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma. J Support Oncol (2007) 0.96
Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women. J Am Coll Radiol (2009) 0.96
Incidence of reduced chemotherapy relative dose intensity among women with early stage breast cancer in US clinical practice. Breast Cancer Res Treat (2012) 0.96
Adherence with migraine prophylaxis in clinical practice. Pain Pract (2012) 0.95
The financial implications for Medicare of greater use of peritoneal dialysis. Clin Ther (2009) 0.95
Patterns of healthcare utilization and cost in patients with newly diagnosed fibromyalgia. Am J Manag Care (2010) 0.92
Patterns of pharmacotherapy and health care utilization and costs prior to total hip or total knee replacement in patients with osteoarthritis. Arthritis Rheum (2011) 0.91
Cost-effectiveness of abatacept in patients with moderately to severely active rheumatoid arthritis and inadequate response to tumor necrosis factor-alpha antagonists. J Rheumatol (2008) 0.90
Blood pressure control in patients initiating antihypertensive therapy. Ann Pharmacother (2008) 0.89
Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer (2014) 0.89
Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother (2004) 0.88
Impact of skeletal complications on total medical care costs among patients with bone metastases of lung cancer. J Thorac Oncol (2006) 0.88
Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin (2008) 0.88
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databases. BMC Health Serv Res (2013) 0.88
Risperidone versus Conventional Antipsychotics for Schizophrenia and Schizoaffective Disorder : Symptoms, Quality of Life and Resource Use under Customary Clinical Care. Clin Drug Investig (2004) 0.87
Clinical and economic outcomes in patients with community-acquired Staphylococcus aureus pneumonia. J Hosp Med (2010) 0.87
Cost-effectiveness of tacrolimus ointment versus pimecrolimus cream in adults with atopic dermatitis. J Drugs Dermatol (2010) 0.86
Initial treatment failure in patients with complicated skin and skin structure infections. Surg Infect (Larchmt) (2013) 0.86
Patterns of initial antibiotic therapy for community-acquired pneumonia in U.S. hospitals, 2000 to 2009. Am J Med Sci (2014) 0.85
Initial treatment failure in non-ICU community-acquired pneumonia: risk factors and association with length of stay, total hospital charges, and mortality. J Med Econ (2013) 0.85
Economic consequences of venous thromboembolism following major orthopedic surgery. Ann Pharmacother (2004) 0.85
Cost-effectiveness of memantine in moderate-to-severe Alzheimer's disease patients receiving donepezil. Curr Med Res Opin (2007) 0.85
Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurol (2012) 0.84
Magnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorder. BMC Geriatr (2009) 0.84
The impact of seizures and adverse effects on global health ratings. Epilepsy Behav (2007) 0.84
Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder. Ann Pharmacother (2012) 0.84
Cost of venous thromboembolism following major orthopedic surgery in hospitalized patients. Am J Health Syst Pharm (2002) 0.83
Treatment of peripheral neuropathic pain: a simulation model. Eur J Pain (2005) 0.83
Changes in healthcare utilization and costs associated with sildenafil therapy for pulmonary arterial hypertension: a retrospective cohort study. BMC Pulm Med (2012) 0.83